ValiRx plc (LON:VAL – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 0.26 and traded as low as GBX 0.14. ValiRx shares last traded at GBX 0.14, with a volume of 4,121,096 shares trading hands.
ValiRx Trading Up 6.7%
The stock’s 50 day simple moving average is GBX 0.17 and its 200 day simple moving average is GBX 0.26. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.27 and a current ratio of 4.62. The firm has a market cap of £2.11 million, a PE ratio of -0.30 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings data on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. The company had revenue of GBX 3 million for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%. On average, sell-side analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
